Pluri Inc. - Asset Resilience Ratio

Latest as of December 2025: 25.47%

Pluri Inc. (PLUR) has an Asset Resilience Ratio of 25.47% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read PLUR liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

$7.79 Million

Cash + Short-term Investments

Total Assets

$30.60 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2007–2025)

This chart shows how Pluri Inc.'s Asset Resilience Ratio has changed over time. See PLUR book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Pluri Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Pluri Inc..

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$7.79 Million	25.47%
Total Liquid Assets	$7.79 Million	25.47%

Asset Resilience Insights

Very High Liquidity: Pluri Inc. maintains exceptional liquid asset reserves at 25.47% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Pluri Inc. Industry Peers by Asset Resilience Ratio

Compare Pluri Inc.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Apellis Pharmaceuticals Inc NASDAQ:APLS	Biotechnology	0.58%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
BioArctic AB (publ) ST:BIOA-B	Biotechnology	72.35%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%

Annual Asset Resilience Ratio for Pluri Inc. (2007–2025)

The table below shows the annual Asset Resilience Ratio data for Pluri Inc..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	38.05%	$14.72 Million	$38.68 Million	-20.65pp
2024-06-30	58.70%	$23.20 Million	$39.53 Million	-9.83pp
2023-06-30	68.53%	$34.81 Million	$50.80 Million	+2.06pp
2022-06-30	66.47%	$45.24 Million	$68.06 Million	+30.43pp
2021-06-30	36.04%	$33.71 Million	$93.54 Million	-21.21pp
2020-06-30	57.25%	$37.51 Million	$65.53 Million	-5.35pp
2019-06-30	62.60%	$19.60 Million	$31.31 Million	+8.49pp
2018-06-30	54.10%	$21.08 Million	$38.96 Million	-2.91pp
2017-06-30	57.01%	$21.40 Million	$37.53 Million	+0.45pp
2016-06-30	56.56%	$25.98 Million	$45.94 Million	+13.40pp
2015-06-30	43.16%	$29.42 Million	$68.16 Million	-23.59pp
2014-06-30	66.75%	$49.41 Million	$74.02 Million	+1.04pp
2013-06-30	65.71%	$44.89 Million	$68.32 Million	+50.90pp
2012-06-30	14.81%	$7.02 Million	$47.42 Million	-10.13pp
2009-06-30	24.94%	$1.11 Million	$4.46 Million	-8.13pp
2008-06-30	33.06%	$1.19 Million	$3.58 Million	-22.81pp
2007-06-30	55.87%	$3.76 Million	$6.73 Million	--

pp = percentage points

About Pluri Inc.

NASDAQ:PLUR USA Biotechnology

Market Cap

$27.32 Million

Market Cap Rank

#24022 Global

#4955 in USA

Share Price

$3.35

Change (1 day)

-3.76%

52-Week Range

$2.92 - $5.79

All Time High

$160.00